Strategic partnership Grace Bio-Labs recently partnered with Arrayjet Ltd in January 2026 to open a US printing suite in Bend, Oregon. This collaboration signals an expanded distribution and integrated workflow capability which could open co-selling opportunities and bundled product offerings for protein microarrays and imaging reagents.

Growth opportunity With a revenue range of 10 to 25 million and a small to mid-size employee base, Grace Bio-Labs is positioned for accelerated growth. Target multi-product deals that combine their sealed chamber solutions with protein microarray slides to increase reagent utilization and assay throughput for biotech and diagnostics customers.

complementary stack Grace Bio-Labs’ products are designed to work together in proteomic, genomic, tissue and cell analysis. Propose bundled sales and co-marketing with compatible platforms or service providers to create end-to-end workflows, leveraging their ONCYTE nitrocellulose slides and related reagents.

Global expansion fit The presence of Shopify and Magento in their tech stack along with logistics references (DHL) suggests a commerce-enabled, potentially global reach. Discuss scalable ecommerce partnerships or distribution agreements that support international sales of chambers, seals, and microarray products.

Key audience Target large life sciences distributors and contract research organizations that require high-sensitivity proteomics and genomics assays. Their focus on minimizing reagent use and enabling rapid setup aligns with customers seeking cost efficiency, faster turnaround times, and high assay throughput.